Real-time enrollment status for this solid tumor, adult clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:35 PM UTC
| NCT Number | NCT06265688 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor, Adult |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 8 sites in the US |
| Sponsor | CytomX Therapeutics |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of October 12, 2026: Clinical trial NCT06265688 is currently recruiting participants. This phase1 study for solid tumor, adult is actively seeking new participants at 8 locations across the United States. The study is sponsored by CytomX Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06265688 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06265688 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.